Gene Editing (BK2569) Stock Forum and Discussion

Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

1440.898
+2.789+0.19%

Close Mar 27 16:00 ET

1450.277High1434.366Low

Constituent Stocks: 10Top Rising: CRBU+12.15%

Trytosaveabit

4 hours ago

news

$Beam Therapeutics (BEAM.US)$ Reuters· 1 min ago
Beam Therapeutics Announces Clearance of Investigational New Drug Application for Beam-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (Aatd) by the United States (U.S.) Food and Drug Administration

MrJav

12 hours ago

$Beam Therapeutics (BEAM.US)$ why id this going down?, is there going to ve any big movements any time soon?

Kujo Jotaro

Mar 26 20:02

$Intellia Therapeutics (NTLA.US)$ Is gonna explode.

Jaguar8

Mar 21 20:24

Filing

$bluebird bio (BLUE.US)$
bluebird bio has entered into a definitive agreement to be acquired by Carlyle and SK Capital in a deal valuing the company at up to $9.84 per share. Shareholders will receive $3.00 per share in cash plus a contingent value right of $6.84 per share, payable if the company achieves $600 million in net sales within a specified period ending December 31, 2027.
The transaction comes after bluebird's comprehensive strategic review involving over 70 potential investors, ...